Current Medical Imaging
Title: Editorial
Volume: 5
Author(s): E. Edmund Kim
Affiliation:
Export Options
About this article
Cite this article as:
Kim Edmund E., Editorial, Current Medical Imaging 2009; 5 (2) . https://dx.doi.org/10.2174/157340509788185333
DOI https://dx.doi.org/10.2174/157340509788185333 |
Print ISSN 1573-4056 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6603 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine Is Src a Viable Target for Treating Solid Tumours?
Current Cancer Drug Targets Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins
Current Pharmaceutical Design LOH12CR1 is a Novel Tumor Suppressor Inhibiting Tumor Growth Through Deregulation of G1/S Checkpoint in Human Colorectal Carcinoma
Current Molecular Medicine The Endocannabinoid System in the Cancer Therapy: An Overview
Current Medicinal Chemistry Molecular Signatures of Biomarkers in Cancer Development, Diagn osis, and its Prognostic Accuracy
Current Biomarkers (Discontinued) Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Regulation of Leptin Receptor Expression in Human Polarized Caco-2/15 Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer
Current Medicinal Chemistry Lynch Syndrome: Awareness among Medical Students at a United States Medical School
Current Women`s Health Reviews GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma
Current Drug Targets The Genetic Basis of New Treatment Modalities in Melanoma
Current Drug Targets PRAME/EZH2-Mediated Regulation of TRAIL: A New Target for Cancer Therapy
Current Molecular Medicine Bioinformatics of Protein-Protein Interfaces and Small Molecule Effectors
Current Bioinformatics Editorial (Thematic Issue: Targeted Anti-Cancer Drug Delivery)
Current Cancer Drug Targets Opportunities to Exploit Non-Neutralizing HIV-Specific Antibody Activity
Current HIV Research The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Current Medicinal Chemistry The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry